Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19 : the COVID-19 SEIMC score
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVE: To develop and validate a prediction model of mortality in patients with COVID-19 attending hospital emergency rooms.
DESIGN: Multivariable prognostic prediction model.
SETTING: 127 Spanish hospitals.
PARTICIPANTS: Derivation (DC) and external validation (VC) cohorts were obtained from multicentre and single-centre databases, including 4035 and 2126 patients with confirmed COVID-19, respectively.
INTERVENTIONS: Prognostic variables were identified using multivariable logistic regression.
MAIN OUTCOME MEASURES: 30-day mortality.
RESULTS: Patients' characteristics in the DC and VC were median age 70 and 61 years, male sex 61.0% and 47.9%, median time from onset of symptoms to admission 5 and 8 days, and 30-day mortality 26.6% and 15.5%, respectively. Age, low age-adjusted saturation of oxygen, neutrophil-to-lymphocyte ratio, estimated glomerular filtration rate by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, dyspnoea and sex were the strongest predictors of mortality. Calibration and discrimination were satisfactory with an area under the receiver operating characteristic curve with a 95% CI for prediction of 30-day mortality of 0.822 (0.806-0.837) in the DC and 0.845 (0.819-0.870) in the VC. A simplified score system ranging from 0 to 30 to predict 30-day mortality was also developed. The risk was considered to be low with 0-2 points (0%-2.1%), moderate with 3-5 (4.7%-6.3%), high with 6-8 (10.6%-19.5%) and very high with 9-30 (27.7%-100%).
CONCLUSIONS: A simple prediction score, based on readily available clinical and laboratory data, provides a useful tool to predict 30-day mortality probability with a high degree of accuracy among hospitalised patients with COVID-19.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:76 |
---|---|
Enthalten in: |
Thorax - 76(2021), 9 vom: 25. Sept., Seite 920-929 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Berenguer, Juan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical epidemiology |
---|
Anmerkungen: |
Date Completed 30.08.2021 Date Revised 30.08.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1136/thoraxjnl-2020-216001 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321909747 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321909747 | ||
003 | DE-627 | ||
005 | 20231225180909.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/thoraxjnl-2020-216001 |2 doi | |
028 | 5 | 2 | |a pubmed24n1072.xml |
035 | |a (DE-627)NLM321909747 | ||
035 | |a (NLM)33632764 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Berenguer, Juan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19 |b the COVID-19 SEIMC score |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.08.2021 | ||
500 | |a Date Revised 30.08.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a OBJECTIVE: To develop and validate a prediction model of mortality in patients with COVID-19 attending hospital emergency rooms | ||
520 | |a DESIGN: Multivariable prognostic prediction model | ||
520 | |a SETTING: 127 Spanish hospitals | ||
520 | |a PARTICIPANTS: Derivation (DC) and external validation (VC) cohorts were obtained from multicentre and single-centre databases, including 4035 and 2126 patients with confirmed COVID-19, respectively | ||
520 | |a INTERVENTIONS: Prognostic variables were identified using multivariable logistic regression | ||
520 | |a MAIN OUTCOME MEASURES: 30-day mortality | ||
520 | |a RESULTS: Patients' characteristics in the DC and VC were median age 70 and 61 years, male sex 61.0% and 47.9%, median time from onset of symptoms to admission 5 and 8 days, and 30-day mortality 26.6% and 15.5%, respectively. Age, low age-adjusted saturation of oxygen, neutrophil-to-lymphocyte ratio, estimated glomerular filtration rate by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, dyspnoea and sex were the strongest predictors of mortality. Calibration and discrimination were satisfactory with an area under the receiver operating characteristic curve with a 95% CI for prediction of 30-day mortality of 0.822 (0.806-0.837) in the DC and 0.845 (0.819-0.870) in the VC. A simplified score system ranging from 0 to 30 to predict 30-day mortality was also developed. The risk was considered to be low with 0-2 points (0%-2.1%), moderate with 3-5 (4.7%-6.3%), high with 6-8 (10.6%-19.5%) and very high with 9-30 (27.7%-100%) | ||
520 | |a CONCLUSIONS: A simple prediction score, based on readily available clinical and laboratory data, provides a useful tool to predict 30-day mortality probability with a high degree of accuracy among hospitalised patients with COVID-19 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Validation Study | |
650 | 4 | |a clinical epidemiology | |
650 | 4 | |a critical care | |
650 | 4 | |a emergency medicine | |
650 | 4 | |a pneumonia | |
650 | 4 | |a respiratory infection | |
650 | 4 | |a viral infection | |
650 | 7 | |a Oxygen |2 NLM | |
650 | 7 | |a S88TT14065 |2 NLM | |
700 | 1 | |a Borobia, Alberto M |e verfasserin |4 aut | |
700 | 1 | |a Ryan, Pablo |e verfasserin |4 aut | |
700 | 1 | |a Rodríguez-Baño, Jesús |e verfasserin |4 aut | |
700 | 1 | |a Bellón, Jose M |e verfasserin |4 aut | |
700 | 1 | |a Jarrín, Inmaculada |e verfasserin |4 aut | |
700 | 1 | |a Carratalà, Jordi |e verfasserin |4 aut | |
700 | 1 | |a Pachón, Jerónimo |e verfasserin |4 aut | |
700 | 1 | |a Carcas, Antonio J |e verfasserin |4 aut | |
700 | 1 | |a Yllescas, María |e verfasserin |4 aut | |
700 | 1 | |a Arribas, José R |e verfasserin |4 aut | |
700 | 0 | |a COVID-19@Spain and COVID@HULP Study Groups |e verfasserin |4 aut | |
700 | 1 | |a Aznar, Esther |e investigator |4 oth | |
700 | 1 | |a Gil, Pedro |e investigator |4 oth | |
700 | 1 | |a Gonzalez, Patricia |e investigator |4 oth | |
700 | 1 | |a Muñoz, Clara |e investigator |4 oth | |
700 | 1 | |a López, Juan C |e investigator |4 oth | |
700 | 1 | |a Ramírez-Schacke, Margarita |e investigator |4 oth | |
700 | 1 | |a Gutiérrez, Isabel |e investigator |4 oth | |
700 | 1 | |a Tejerina, Francisco |e investigator |4 oth | |
700 | 1 | |a Aldámiz-Echevarría, Teresa |e investigator |4 oth | |
700 | 1 | |a Díez, Cristina |e investigator |4 oth | |
700 | 1 | |a Fanciulli, Chiara |e investigator |4 oth | |
700 | 1 | |a Pérez-Latorre, Leire |e investigator |4 oth | |
700 | 1 | |a Parras, Francisco |e investigator |4 oth | |
700 | 1 | |a Catalán, Pilar |e investigator |4 oth | |
700 | 1 | |a García-Leoni, María E |e investigator |4 oth | |
700 | 1 | |a Pérez-Tamayo, Isabel |e investigator |4 oth | |
700 | 1 | |a Puente, Luis |e investigator |4 oth | |
700 | 1 | |a Cedeño, Jamil |e investigator |4 oth | |
700 | 1 | |a Díaz, Marta |e investigator |4 oth | |
700 | 1 | |a Calle, Fernando de la |e investigator |4 oth | |
700 | 1 | |a Arsuaga, Marta |e investigator |4 oth | |
700 | 1 | |a Trigo, Elena |e investigator |4 oth | |
700 | 1 | |a Del Mar Lago, M |e investigator |4 oth | |
700 | 1 | |a Miguel, Rosa de |e investigator |4 oth | |
700 | 1 | |a Cadiñaños, Julen |e investigator |4 oth | |
700 | 1 | |a Busca, Carmen |e investigator |4 oth | |
700 | 1 | |a Mican, Alfredo |e investigator |4 oth | |
700 | 1 | |a Mora, Marta |e investigator |4 oth | |
700 | 1 | |a Ramos, Juan Carlos |e investigator |4 oth | |
700 | 1 | |a Loeches, Belén |e investigator |4 oth | |
700 | 1 | |a Bernardino, José I |e investigator |4 oth | |
700 | 1 | |a García, Julio |e investigator |4 oth | |
700 | 1 | |a Such, Ana |e investigator |4 oth | |
700 | 1 | |a Álvaro, Elena |e investigator |4 oth | |
700 | 1 | |a Izquierdo, Elsa |e investigator |4 oth | |
700 | 1 | |a Torres, Juan |e investigator |4 oth | |
700 | 1 | |a Cuevas, Guillermo |e investigator |4 oth | |
700 | 1 | |a Troya, Jesús |e investigator |4 oth | |
700 | 1 | |a Mestre, Beatriz |e investigator |4 oth | |
700 | 1 | |a Jiménez, Eva |e investigator |4 oth | |
700 | 1 | |a Fernandez, Inés |e investigator |4 oth | |
700 | 1 | |a Tebar, Ana J |e investigator |4 oth | |
700 | 1 | |a Brañas, Fátima |e investigator |4 oth | |
700 | 1 | |a Valencia, Jorge |e investigator |4 oth | |
700 | 1 | |a Pérez, Mario |e investigator |4 oth | |
700 | 1 | |a Alvarado, Marta |e investigator |4 oth | |
700 | 1 | |a Ryan, Pablo |e investigator |4 oth | |
700 | 1 | |a Antonia Sepúlveda, M |e investigator |4 oth | |
700 | 1 | |a Yera, Carmen |e investigator |4 oth | |
700 | 1 | |a Toledano, Pilar |e investigator |4 oth | |
700 | 1 | |a Cano, Verónica |e investigator |4 oth | |
700 | 1 | |a Zafar, Sadaf |e investigator |4 oth | |
700 | 1 | |a Muñiz, Gema |e investigator |4 oth | |
700 | 1 | |a Martín, Inmaculada |e investigator |4 oth | |
700 | 1 | |a Mozas, Helena |e investigator |4 oth | |
700 | 1 | |a Alguacil, Ana |e investigator |4 oth | |
700 | 1 | |a Paz García, M |e investigator |4 oth | |
700 | 1 | |a Peláez, Ana I |e investigator |4 oth | |
700 | 1 | |a Morcillo, Elena |e investigator |4 oth | |
700 | 1 | |a Goikoetxea, Josune |e investigator |4 oth | |
700 | 1 | |a José Blanco, M |e investigator |4 oth | |
700 | 1 | |a Nieto, Javier |e investigator |4 oth | |
700 | 1 | |a Álamo, Mikel Del |e investigator |4 oth | |
700 | 1 | |a Isabel, A |e investigator |4 oth | |
700 | 1 | |a Pérez, Pérez Inés |e investigator |4 oth | |
700 | 1 | |a Silvariño, Rafael |e investigator |4 oth | |
700 | 1 | |a Ugalde, Jon |e investigator |4 oth | |
700 | 1 | |a Asensi, Víctor |e investigator |4 oth | |
700 | 1 | |a Suárez, Lucia |e investigator |4 oth | |
700 | 1 | |a Suárez, Silvia |e investigator |4 oth | |
700 | 1 | |a Yllera, Carmen |e investigator |4 oth | |
700 | 1 | |a Boix, Vicente |e investigator |4 oth | |
700 | 1 | |a Díez, Marcos |e investigator |4 oth | |
700 | 1 | |a Carreres, Melissa |e investigator |4 oth | |
700 | 1 | |a Gómez-Ayerbe, Cristina |e investigator |4 oth | |
700 | 1 | |a Sánchez-Lora, Javier |e investigator |4 oth | |
700 | 1 | |a Velasco, José L |e investigator |4 oth | |
700 | 1 | |a López-Jódar, María |e investigator |4 oth | |
700 | 1 | |a Santos, Jesús |e investigator |4 oth | |
700 | 1 | |a Ruiz, Jesús |e investigator |4 oth | |
700 | 1 | |a Virto, Ianire |e investigator |4 oth | |
700 | 1 | |a Alende, Vanessa |e investigator |4 oth | |
700 | 1 | |a Brea, Ruth |e investigator |4 oth | |
700 | 1 | |a Vega, Sonia |e investigator |4 oth | |
700 | 1 | |a Pons, Estel |e investigator |4 oth | |
700 | 1 | |a Río, Oscar Del |e investigator |4 oth | |
700 | 1 | |a Valero, Silvia |e investigator |4 oth | |
700 | 1 | |a Villar-García, Judit |e investigator |4 oth | |
700 | 1 | |a Gómez-Junyent, Joan |e investigator |4 oth | |
700 | 1 | |a Knobel, Hernando |e investigator |4 oth | |
700 | 1 | |a Cecilia Cánepa, M |e investigator |4 oth | |
700 | 1 | |a Castañeda, Silvia |e investigator |4 oth | |
700 | 1 | |a Sorli, Luisa |e investigator |4 oth | |
700 | 1 | |a Güerri-Fernández, Roberto |e investigator |4 oth | |
700 | 1 | |a Milagro, María |e investigator |4 oth | |
700 | 1 | |a Horcajada, Juan P |e investigator |4 oth | |
700 | 1 | |a García, Elisa |e investigator |4 oth | |
700 | 1 | |a Moral, Encarnación |e investigator |4 oth | |
700 | 1 | |a Hernádez, Alicia |e investigator |4 oth | |
700 | 1 | |a García, Esther |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Thorax |d 1946 |g 76(2021), 9 vom: 25. Sept., Seite 920-929 |w (DE-627)NLM00010387X |x 1468-3296 |7 nnns |
773 | 1 | 8 | |g volume:76 |g year:2021 |g number:9 |g day:25 |g month:09 |g pages:920-929 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/thoraxjnl-2020-216001 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 76 |j 2021 |e 9 |b 25 |c 09 |h 920-929 |